A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.

PubWeight™: 2.53‹?› | Rank: Top 2%

🔗 View Article (PMID 17047087)

Published in Cancer Res on October 15, 2006

Authors

Rachael Z Stolzenberg-Solomon1, Reinhold Vieth, Azar Azad, Pirjo Pietinen, Philip R Taylor, Jarmo Virtamo, Demetrius Albanes

Author Affiliations

1: Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health Human Services, Rockville, Maryland 20852, USA. rs221z@nih.gov

Associated clinical trials:

Genetic, Dietary and Environmental Influences on Vitamin D Metabolism | NCT02590614

Articles citing this

Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst (2008) 3.04

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev (2011) 1.94

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res (2009) 1.67

The high prevalence of hypovitaminosis D in China: a multicenter vitamin D status survey. Medicine (Baltimore) (2015) 1.60

Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer (2007) 1.60

Vitamin D metabolic pathway genes and pancreatic cancer risk. PLoS One (2015) 1.51

Chemoprevention strategies for pancreatic cancer. Nat Rev Gastroenterol Hepatol (2010) 1.38

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.37

Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.33

Vitamin D: The "sunshine" vitamin. J Pharmacol Pharmacother (2012) 1.24

Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res (2012) 1.24

Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer (2010) 1.19

Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev (2007) 1.16

Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol (2008) 1.15

How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermatoendocrinol (2009) 1.13

Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res (2010) 1.12

Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab (2010) 1.11

The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol (2009) 1.06

Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland. Eur J Clin Nutr (2010) 1.04

Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men. Am J Epidemiol (2011) 0.97

Apc(MIN) modulation of vitamin D secosteroid growth control. Carcinogenesis (2010) 0.94

Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol (2009) 0.92

Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Am J Epidemiol (2009) 0.91

Vitamin D and pancreatic cancer. Ann Epidemiol (2008) 0.90

Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control (2010) 0.90

Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J (2010) 0.89

Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health (2007) 0.86

Is dietary fat, vitamin D, or folate associated with pancreatic cancer? Mol Carcinog (2012) 0.86

Nutrigenomics, vitamin D and cancer prevention. J Nutrigenet Nutrigenomics (2011) 0.86

Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis. PLoS One (2011) 0.85

Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermatoendocrinol (2016) 0.85

Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature. Exp Ther Med (2011) 0.85

Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Ann Oncol (2014) 0.84

Vitamin d: are we ready to supplement for breast cancer prevention and treatment? ISRN Oncol (2013) 0.83

Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. Cancer Epidemiol Biomarkers Prev (2010) 0.82

25OHD analogues and vacuum blood collection tubes dramatically affect the accuracy of automated immunoassays. Sci Rep (2015) 0.82

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men. Cancer Epidemiol Biomarkers Prev (2011) 0.82

Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation. Dermatoendocrinol (2009) 0.80

Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Ann Oncol (2015) 0.80

Vitamin D and extra-skeletal health: causality or consequence. Int J Health Sci (Qassim) (2016) 0.79

An ecological study of cancer mortality rates in California, 1950-64, with respect to solar UVB and smoking indices. Dermatoendocrinol (2012) 0.79

The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D. Dermatoendocrinol (2016) 0.79

Vitamin D in the cancer patient. Curr Opin Support Palliat Care (2013) 0.78

Vitamin d and pancreatic cancer-an update. Cancers (Basel) (2011) 0.78

Predictors of vitamin D status in subjects that consume a vitamin D supplement. Eur J Clin Nutr (2014) 0.78

Vitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trials. Womens Health (Lond Engl) (2011) 0.78

Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am (2015) 0.77

Vitamin D-binding protein and pancreatic cancer: a nested case-control study. Am J Clin Nutr (2015) 0.76

Vitamin D and pancreatic cancer risk in the alpha-tocopherol, beta-carotene cancer prevention cohort. Cancer Res (2006) 0.75

Is UV an etiological factor of acral melanoma? J Expo Sci Environ Epidemiol (2015) 0.75

The vitamin D system is deregulated in pancreatic diseases. J Steroid Biochem Mol Biol (2014) 0.75

Rediscovering vitamin D. Libyan J Med (2010) 0.75

Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma. Oncotarget (2016) 0.75

Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis. Oncotarget (2017) 0.75

Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation. Front Oncol (2017) 0.75

Articles by these authors

Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med (2002) 4.87

Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69

The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36

Risk assessment for vitamin D. Am J Clin Nutr (2007) 4.34

Tissue-resident macrophages. Nat Immunol (2013) 4.09

Genome-wide association study of circulating vitamin D levels. Hum Mol Genet (2010) 4.07

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2006) 4.02

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93

Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity (2013) 3.26

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18

Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med (2009) 3.12

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07

Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst (2008) 3.04

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99

Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96

Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol (2013) 2.87

Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol (2005) 2.87

Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol (2002) 2.83

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76

Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71

Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (2006) 2.64

Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol (2008) 2.62

Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care (2010) 2.61

Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60

Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr (2012) 2.56

Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54

Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA (2003) 2.50

A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res (2009) 2.48

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst (2006) 2.48

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43

An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem (2009) 2.41

The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay. Acta Oncol (2002) 2.40

Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol (2003) 2.38

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer (2007) 2.29

Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med (2007) 2.23

Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res (2005) 2.22

The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr (2006) 2.19

Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA (2002) 2.19

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis (2009) 2.17

Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study. Hepatology (2014) 2.14

Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol (2012) 2.08

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2009) 2.06

A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res (2006) 2.02